82.9
Anika Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
73.2
FY23:
82.5
FY24:
76.0
FY25:
63.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
67.5
FY22:
44.3
FY23:
39.1
FY24:
38.8
FY25:
38.0
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
3.02
FY25:
−5.32
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.43
FY22:
4.32
FY23:
3.16
FY24:
−2.76
FY25:
−9.31
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.13
FY22:
−14.9
FY23:
−82.7
FY24:
−56.4
FY25:
−10.9
All amounts in millions USD